MacroGenics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (25)

View All

Latest Posts

About This Stock More About This Stock
MicroMarvel: MacroGenics Confuses Wall Street
Article By: Jim Van Meerten
Monday, February 5, 2024 11:29 AM EDT
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States.
In this article: MGNX
Read
Week In Review: BeiGene Forges $1.3 Billion Bi-Specific Antibody Deal With Zymeworks
Article By: ChinaBio® Today
Saturday, December 1, 2018 4:44 PM EDT
BeiGene of Beijing announced cancer drug deals worth up to $1.3 billion with Vancouver's Zymeworks. BeiGene will acquire Asian rights to two bispecific antibodies from Zymeworks and will have rights to three to-be-discovered bispecific candidates.
In this article: LLY, HCM, BGNE, MGNX, ZLAB, TCON, ZYME, BHVN
Read
Morning Call For Tuesday, Dec. 27
Article By: Jim Van Meerten
Tuesday, December 27, 2016 9:46 AM EDT
Mar E-mini S&Ps (ESH17 +0.06%) are up +0.06% and European stocks are up +0.10% in thin holiday trade. Markets in the UK, Australia and Hong Kong are closed today for holiday.
In this article: BID, DIS, DV, LGF, RBA, WLL, PLX, HOLX, SHPG, MGNX
Read
All Posts

Latest Tweets for $MGNX

No tweets yet!

PARTNER HEADLINES